Taikang Asset Management (Hong Kong) CO LTD Legend Biotech Corp Transaction History
Taikang Asset Management (Hong Kong) CO LTD
- $667 Million
- Q4 2024
A detailed history of Taikang Asset Management (Hong Kong) CO LTD transactions in Legend Biotech Corp stock. As of the latest transaction made, Taikang Asset Management (Hong Kong) CO LTD holds 100,475 shares of LEGN stock, worth $3.6 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
100,475
Previous 48,330
107.89%
Holding current value
$3.6 Million
Previous $2.36 Million
38.81%
% of portfolio
0.49%
Previous 0.25%
Shares
5 transactions
Others Institutions Holding LEGN
# of Institutions
229Shares Held
78.4MCall Options Held
229KPut Options Held
372K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$401 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$269 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$238 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$205 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$205 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...